Banner Alzheimer’s Institute presents outcomes from Navidea AZD4694 research at 6th Annual HAI Navidea Biopharmaceuticals, Inc. today announced that the Banner Alzheimer’s Institute, Phoenix, AZ, produced two presentations of outcomes from an AstraZeneca-sponsored research on the evaluation of Navidea’s late-stage radiopharmaceutical imaging applicant, AZD4694, at the 6th Annual Individual Amyloid Imaging Achieving , in Miami, FL. In 2011 December, Navidea in-certified the worldwide unique rights to AZD4694 from AstraZeneca, today being produced by Navidea as a radiopharmaceutical agent for the recognition of cerebral amyloid in Alzheimer’s disease sufferers.Pig vaccination programme before summer months On Japanese encephalitis, Dr Chow said it had been neither appropriate nor necessary to implement a individual vaccination programme at this time as there were unwanted effects. But a pig vaccination program was being exercised with the sector and would take place before next summer. Embracing welfare problems, Dr Chow stated if inflation continuing, there could be a need to consider increasing extensive public assistance. But he stressed that at present, with housing, education and medical subsidies along with comprehensive social assistance, there was a safety net for the needy locally already.